Ani Pharmaceuticals Inc: president & CEO Nikhil Lalwani sold 5,400 shares

What happened Nikhil Lalwani, president & CEO and director, sold 5,400 shares in open-market or private sales on Oct 15, 2026, at a weighted average price of $71.89 per share, for $388,206, as reported on Form 4 filed Oct 16, 2026.

Key details

• Transaction date and prices: Oct 15, 2026; sales executed in multiple trades at prices ranging from $71.08 to $72.56; weighted average $71.89 per share.
• Transaction type: Sale (code S).
• Shares owned after the transaction: not stated in this Form 4.
• Footnotes: F1—sales were effected pursuant to a Rule 10b5-1 trading plan adopted May 26, 2026; F2—sales occurred in multiple trades, price range $71.08 to $72.56, weighted average reported.
• Filing: Form 4 filed on Oct 16, 2026 (accession 0001822629-26-000018).

Why it may matter

• The filing reports a market sale under a pre-established Rule 10b5-1 trading plan adopted May 26, 2026.
• This filing does not show why the insider traded or why the company acted.